The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder Tumors
Abstract
PURPOSES: Fluorescence diagnosis induced by 5-aminolevulinic acid enables more thorough transurethral resection of superficial bladder carcinoma compared with conventional white light. We performed a prospective, single institution, randomized trial to investigate whether the residual tumor rate and long-term tumor recurrence can be decreased by fluorescence diagnosis. MATERIALS AND METHODS: A total of 301 patients underwent transurethral resection of bladder tumors with white light or fluorescence diagnosis. Transurethral resection was repeated 5 to 6 weeks later to evaluate the residual tumor rate. To determine recurrence-free survival patient followup was performed every 3 months by white light cystoscopy and urine cytology. Recurrence-free survival was analyzed via Kaplan-Meier methods and multivariable Cox regression analysis. RESULTS: A total of 191 patients with superficial bladder carcinoma were available for efficacy analysis. The residual tumor rate was 25.2% in the white light arm versus 4.5% in the fluorescence diagnosis arm (p <0.0001). Median followup in the white light arm in 103 cases was 21.2 months (range 4 to 40) compared with 20.5 (range 3 to 40) in the 88 in the fluorescence diagnosis arm. Recurrence-free survival in the fluorescence diagnosis group was 89.6% after 12 and 24 months compared with 73.8% and 65.9%, respectively, in the white light group (p = 0.004). This superiority proved to be independent of risk group. The adjusted hazard ratio of fluorescence diagnosis versus white light transurethral resection was 0.33 (95% confidence interval 0.16 to 0.67). CONCLUSIONS: Fluorescence diagnosis is significantly superior to conventional white light transurethral resection with respect to the residual tumor rate and recurrence-free survival. The differences in recurrence-free survival imply that fluorescence diagnosis is a clinically relevant procedure for decreasing the number of tumor recurrences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kriegmair, M., Ehsan, A., Baumgartner, R., Lumper, W., Knuechel, R., Hofstädter, F., Steinbach, P., & Hofstetter, A. (1994) · Urology · doi:10.1016/s0090-4295(94)80167-3 · Cited by 265
Self-citation
Cited by
Bladder cancer: Epidemiology, staging and grading, and diagnosis
Kirkali, Z., Chan, T., Manoharan, M., Algaba, F., Busch, C., Cheng, L., Kiemeney, L., Kriegmair, M., Montironi, R., Murphy, W. M., et al. (2005) · Urology · doi:10.1016/j.urology.2005.07.062 · Cited by 1,074
Grossman, H. B., Gomella, L., Fradet, Y., Morales, A., Presti, J., Ritenour, C., Nseyo, U., Droller, M. J., & PC B302/01 Study Group (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.034 · Cited by 300
JICHLINSKI, P., GUILLOU, L., KARLSEN, S. J., MALMSTRÖM, P.-U., JOCHAM, D., BRENNHOVD, B., JOHANSSON, E., GÄRTNER, T., LANGE, N., van den BERGH, H., et al. (2003) · Journal of Urology · doi:10.1097/01.ju.0000060782.52358.04 · Cited by 278
Kamat, A. M., Hegarty, P. K., Gee, J. R., Clark, P. E., Svatek, R. S., Hegarty, N., Shariat, S. F., Xylinas, E., Schmitz-Dräger, B. J., Lotan, Y., et al. (2013) · European Urology · doi:10.1016/j.eururo.2012.09.057 · Cited by 263
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives
Fotinos, N., Campo, M. A., Popowycz, F., Gurny, R., & Lange, N. (2006) · Photochemistry and Photobiology · doi:10.1562/2006-02-03-ir-794 · Cited by 238
Metadata
- Authors
- Filbeck, T., Pichlmeier, U., Knuechel, R., Wieland, W. F., & Roessler, W.
- Venue
- Journal of Urology
- Published
- 2002-07
- Volume
- 168
- Issue
- 1
- Pages
- 67-71
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2056758275
- Cited by
- 162
- References
- 1
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder Tumors. https://app.cochat.ai/papers/10.1016/s0022-5347(05)64833-1
- The paper
- Filbeck, T., Pichlmeier, U., Knuechel, R., Wieland, W. F., & Roessler, W. (2002). Clinically Relevant Improvement of Recurrence-free Survival with 5-Aminolevulinic Acid Induced Fluorescence Diagnosis in Patients with Superficial Bladder Tumors. Journal of Urology. https://doi.org/10.1016/s0022-5347(05)64833-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.